UroGen Pharma URGN
NASDAQ URGN
$41.40 +0.85 (+2.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Depreciation & Amortization (CF) (2018 - 2026)

Updated

UroGen Pharma's Depreciation & Amortization (CF) came in at $100,000 for Q2 2026, unchanged from $100,000 a year earlier and unchanged from the prior quarter.

Analysis

UroGen Pharma (URGN) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, UroGen Pharma reported Depreciation & Amortization (CF) of $375,000, up 14.0% year-over-year; for FY2025, it came in at $307,000, down 6.7% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last three years, with a five-year compound annual growth rate of -5.9% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $329,000 in FY2024 (-59.0%), $802,000 in FY2023 (-13.2%), $924,000 in FY2022 (+11.2%) and $831,000 in FY2021 (+99.8%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $29,000 (Q4 2024) to $224,000 (Q4 2022).
  • Year-over-year, Depreciation & Amortization (CF) increased in 1 of the last eight quarters, with growth averaging 0.6%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2025 (growth of 158.6%), and the weakest in Q4 2024 (a decline of 84.7%).
  • Business Quant data shows URGN's Depreciation & Amortization (CF) at $100,000 (Q1 2026), $75,000 (Q4 2025) and $100,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 UroGen Pharma 1.98 Bn 1.49 Bn 65.88 Mn 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 75,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 29,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 123,000.00
Dec 31, 2023 190,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 217,000.00
Dec 31, 2022 224,000.00
Sep 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 215,000.00
Dec 31, 2021 213,000.00
Sep 30, 2021 200,000.00
API Access

UroGen Pharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=URGN&period=max&api_key=YOUR_API_KEY